How lockdown measures, during COVID-19 pandemic, matter on psoriatic patient’s perception: Study on 600 patients on biologic therapy

How lockdown measures, during COVID-19 pandemic, matter on psoriatic patient’s perception: Study on 600 patients on biologic therapy

Background: The outbreak of coronavirus disease-2019 (COVID-19) is a public health crisis of global proportion. In psoriatic patients treated with biologic agents, evidence is not yet available on susceptibility to infection with the novel SARS-CoV-2 coronavirus, and data about the perception of COV...

Full description

Bibliographic Details
Main Authors: N. Bernardini, N. Skroza, A. Spagnoli, A. Marchesiello, V. Balduzzi, E. Tolino, A. Mambrin, S. Michelini, P. Maddalena, S. Volpe, I. Proietti, A. Vestri, C. Potenza
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Journal of Infection and Public Health
Subjects:
Biologic drugs
Coronavirus
COVID-19
Psoriasis
SARS-CoV-2
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034121000769

Internet

http://www.sciencedirect.com/science/article/pii/S1876034121000769

Similar Items